Cellectar Biosciences, Inc. — Net Income by Fiscal Year
23 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5274f011-aeed-4930-89a2-9e70ff60c1ed/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-21.8M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-023167 |
| FY 2024 | $-44.6M | 2024-01-01 – 2024-12-31 | evidence 0001410578-25-000329 |
| FY 2023 | $-42.8M | 2023-01-01 – 2023-12-31 | evidence 0001410578-24-001704 |
| FY 2022 | $-31.8M | 2022-01-01 – 2022-12-31 | evidence 0001410578-24-001704 |
| FY 2021 | $-24.1M | 2021-01-01 – 2021-12-31 | evidence 0001410578-22-000436 |
| FY 2020 | $-15.1M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-030445 |
| FY 2019 | $-14.1M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-030742 |
| FY 2018 | $-13.2M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-009973 |
| FY 2017 | $-13.6M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-016175 |
| FY 2016 | $-6.2M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-014611 |
| FY 2015 | $-5.5M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-087438 |
| FY 2014 | $-8.1M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-032559 |
| FY 2013 | $-54.0M | 2002-11-07 – 2014-03-31 | evidence 0001144204-14-030439 |
| FY 2012 | $-43.7M | 2002-11-07 – 2013-03-31 | evidence 0001144204-13-029551 |
| FY 2011 | $-33.8M | 2002-11-08 – 2012-03-31 | evidence 0001144204-12-026326 |
| FY 2010 | $-4.6M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-014034 |
| FY 2009 | $-6.2M | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-014034 |
| FY 2008 | $-6.1M | 2008-01-01 – 2008-12-31 | evidence 0001144204-12-014034 |
| FY 2007 | $-5.1M | 2007-01-01 – 2007-12-31 | evidence 0001144204-12-014034 |
| FY 2006 | $-963.4k | 2006-01-01 – 2006-12-31 | evidence 0001144204-12-014034 |
| FY 2005 | $-481.8k | 2005-01-01 – 2005-12-31 | evidence 0001144204-12-014034 |
| FY 2004 | $-342.8k | 2004-01-01 – 2004-12-31 | evidence 0001144204-12-014034 |
| FY 2003 | $-295.8k | 2003-01-01 – 2003-12-31 | evidence 0001144204-12-014034 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).